IBA Press Releases
IBA renews exclusive four-year radiopharmaceuticals contract in Andalusia, Spain
Read it in : English
IBA and D-Pace sign an exclusive sales agreement for the supply of Negative Hydrogen Ion sources, based on licensed TRIUMF technology.
Read it in : English
IBA Cyclone® 70 breaks world record performances at ARRONAX in Nantes, France
Read it in : English
IBA and PROCURE set record on development of second Proton Therapy Center
Read it in : English
IBA selected to install a Proton Therapy Center in Knoxville, Tennessee, USA
IBA signs letter of intent to install first Proteus One™ proton beam system at Nice, France proton therapy center.
IBA Introduces Proteus ONE(TM)*, a Smaller, More Cost-Effective Proton Therapy System
IBA Dosimetry Achieves 1000th Clinical MatriXX User Milestone
Read it in : English
IBA Molecular granted FILTRACIS™ Marketing Approval in France
Read it in : English
IBA selected to install the first gantry-equipped proton therapy system of Russia, in Dimitrovgrad
New Industry Partnership will Secure Manufacturing of Radioisotopes for Medical Use in Europe
IBA and Bayer Schering Pharma Sign Clinical Trial Supply Agreement for Alzheimer’s Disease Tracer
Read it in : English
IBA Signs a Contract for the New Proton Therapy Center of Cracow, Poland
ProCure selects IBA one more time as supplier for a Proton Therapy system
IBA Molecular presents an all-new version of its Synthera® at SNM’10
Read it in : English
IBA receives an offer from a leading financial consortium to develop its Bioassays business.
IBA Molecular Addresses Nuclear Medicine Industry's Molybdenum Shortage with Solutions
Read it in : English
REDECTANE® meets both endpoints specificity and sensitivity with superiority over CT in its pivotal Phase III trial
Read it in : English
Frost & Sullivan lauds IBA for its Technology Dominance in the European Radiopharmaceuticals Market
Read it in : English
CE Certification Granted for IBA’s 2nd Generation Pencil Beam Scanning Proton Treatment System
Read it in : English
Dasheng and IBA have entered an exclusive agreement for the distribution of the Dasheng E-beam Accelerators by IBA outside of China.
Read it in : English
New Proton Therapy Order: PROCURE contracts once more with IBA for its new Center in New Jersey
